Atherosclerosis: a global challenge with multifactorial roots
DOI:
https://doi.org/10.37910/RDP.2024.13.3.e405Keywords:
Atherosclerosis, Intestinal microbiota, Autoimmunity, NLRP3 inflammasome, Endothelial dysfunctionAbstract
The scientific interest that exists in the mechanisms involved in the process that gives rise to atherosclerosis is considerably notable and important. The large volume of articles and knowledge on this topic is increasing, allowing us to constantly delve deeper into the pathophysiological mechanisms that comprise atherosclerosis, the risk factors that predispose to it, and the possible consequences to be expected once the pathology is triggered. It is now known that the multifactorial nature of this abnormal situation of the arteries is what has led to the high morbidity and mortality that cardiovascular diseases currently represent. Objective: To investigate the mechanisms of atherosclerosis: To delve deeper into the pathophysiological processes that lead to the development of this disease. To understand how different elements, including immunity, genetics and microbiota, contribute to the development of atherosclerosis. Methods: A review of the existing scientific literature on the subject was carried out. Analysis of studies that relate risk factors (hormonal, environmental and genetic) with the development of the disease. Research on the role of the immune system and microbiota in the pathophysiology of atherosclerosis. It has been possible to elucidate the different causes, finding a strong relationship between the development of atherosclerosis and various factors, in order to try to explain the pathophysiological substrate that we face in the search for the most effective treatment for this abnormal condition of the organism.
Downloads
References
Sima, P., et al. (2018). "Atherosclerosis as autoimmune disease." Annals of Translational Medicine 6(7): 116.
Hinkley H, Counts DA, VonCanon E, Lacy M. T Cells in Atherosclerosis: Key Players in the Pathogenesis of Vascular Disease. Cells. 2023 Aug. [citado 2024 Jul 23] 26;12(17):2152. Disponible en: https://atm.amegroups.org/article/view/18591/html
Edsfeldt, A., Nilsson, J. Understanding autoimmunity in atherosclerosis paves the way for novel therapies. Nat Cardiovasc Res 2, 227–229 (2023). Disponible en: https://doi.org/10.1038/s44161-023-00230-0.
Shen X, Li L, Sun Z, Zang G, Zhang L, Shao C and Wang Z (2021) Gut Microbiota and Atherosclerosis—Focusing on the Plaque Stability. Front. Cardiovasc. Med. 8:668532. doi: 10.3389/fcvm.2021.668532.
Al Samarraie, A.; Pichette, M.; Rousseau, G. Role of the Gut Microbiome in the Development of Atherosclerotic Cardiovascular Disease. Int. J. Mol. Sci. 2023, 24,5420. Disponible en: https://doi.org/10.3390/ijms24065420.
Wang Z, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472:57–63. [PMC free article] [PubMed] [Google Scholar]16. Poznyak, A. (2023). Sex Differences Define the Vulnerability to Atherosclerosis. Clin Med Insights Cardiol. 2023; 17: 11795468231189044.
Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, et al. Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med [Internet]. 2013 [citado el 20 de junio de 2024];19(5):576–85. Disponible en: http://dx.doi.org/10.1038/nm.3145.
Sakkers TR, Mokry M, Civelek M, Erdmann J, Pasterkamp G, Diez Benavente E, den Ruijter HM. Sex differences in the genetic and molecular mechanisms of coronary artery disease. Atherosclerosis. 2023 Nov;384:117279. doi: 10.1016/j.atherosclerosis.2023.117279. Epub 2023 Oct 5. PMID: 37805337.
Rosser, E. (2022). Mini-Review: Gut-Microbiota and the Sex Blas in Autoimmunity-Lessons Learn from Animal Modelos. Front Med. Disponible en: https://pubmed.ncbi.nlm.nih.gov/35783625/
Teophilis, P. (2023). Review inflammasomes un Atherosclerosis - From Pathophysiology to Treatment. Pharmaceuticals 2023, 16, 1211. https://doi.org/10.3390/ph16091211.
Cimmino G, et all (2023) Pathogenesis Of Atherosclerosis Working Group Of The Italian Society Of Cardiology. Evolving concepts in the pathophysiology of atherosclerosis: from endothelial dysfunction to thrombus formation through multiple shades of inflammation. J Cardiovasc Med (Hagerstown). May 1;24(Suppl 2):e156-e167. doi:10.2459/JCM.0000000000001450. PMID: 37186566.
Elena Rampanelli y Max Nieuwdorp (2023) Microbioma intestinal en la diabetes tipo 1: la perspectiva inmunológica, Revisión de expertos en inmunología clínica, 19:1, 93-109, DOI: 10.1080/1744666X.2023.2150612.
Boerner B, Sarvetnick. N. Type 1 diabetes: role of intestinal microbiome in humans and mice. Annals of the New York A. 2011;1243:103–18.
Camick RMN, Lemos JRN, Hirani K. Gene- environment interaction in the pathophysiology of type 1 diabetes. Frontiers in end. 2024;15.
Ye J, Li L, Wang M, Ma Q, Tian Y, Zhang Q, Liu J, Li B, Zhang B, Liu H and Sun G (2022) Diabetes Mellitus Promotes the Development of Atherosclerosis: The Role of NLRP3. Front. Immunol. 13:900254. doi: 10.3389/fimmu.2022.900254.
Rasouli-Saravani A, Jahankhani K, Moradi S, Gorgani M, Shafaghat Z, Mirsanei Z, et al. Role of microbiota short-chain fatty acids in the pathogenesis of autoimmune diseases. Biomed Pharmacother [Internet]. 2023 [citado el 20 de junio de 2024];162(114620):114620. Disponible en: https://pubmed.ncbi.nlm.nih.gov/37004324/
Markle JGM, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, Rolle-Kampczyk U, et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science [Internet]. 2013 [citado el 20 de junio de 2024];339(6123):1084–8. Disponible en: https://pubmed.ncbi.nlm.nih.gov/23328391/
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Ivan Golfetto, Saúl Araujo, Carlos Jiménez, Izaskun Berecibar, Diana González, Ana Tinoco
This work is licensed under a Creative Commons Attribution 4.0 International License.
Usted es libre de:
- Compartir — copiar y redistribuir el material en cualquier medio o formato
- Adaptar — remezclar, transformar y construir a partir del material
- para cualquier propósito, incluso comercialmente.
Bajo los siguientes términos:
-
Atribución — Usted debe dar crédito de manera adecuada, brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
- No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.